Today the governing Board of the California Institute for Regenerative Medicine (CIRM) expanded efforts related to the $5 million in emergency funding for the CIRM COVID-19 program. The new guidelines mean that inception discovery projects (DISC1), whose goal is developing new and transformational ideas, will now be eligible for CIRM COVID-19 funding. These projects can … Continue reading CIRM Board Expands Efforts of COVID-19 Program
Author: Yimy Villa
Scientists at Gladstone and UCSF form two new research institutes
Dr. Melanie Ott (left) and Dr. Alexander Marson (right)Image Credit: Gladstone Institutes In a previous blog post, we talked about how scientists at the Gladstone Institutes have shifted their current operations towards helping with the current coronavirus pandemic. Now scientists at Gladstone and U.C. San Francisco have formed two new research institutes to broaden its … Continue reading Scientists at Gladstone and UCSF form two new research institutes
Treatment for heart failure shows promising results for COVID-19 patients
Dr. Linda Marbán To help with the coronavirus pandemic, many scientists are repurposing previously developed approaches or treatments to see if they can be used to treat patients with COVID-19. Capricor Therapeutics, lead by Dr. Linda Marbán, is using cardiosphere derived cells (CDCs), which are stem cells derived from heart tissue, to treat critically ill … Continue reading Treatment for heart failure shows promising results for COVID-19 patients
Two UCLA scientists receive CIRM funding for discovery research for COVID-19
Dr. Brigitte Gomperts (left) and Dr. Gay Crooks (right), UCLAImage Credit: UCLA Broad Stem Cell Center This past Friday, the CIRM Board approved funding for its first clinical study for COVID-19. In addition to this, the Board also approved two discovery stage research projects, which support promising new technologies that could be translated to enable … Continue reading Two UCLA scientists receive CIRM funding for discovery research for COVID-19
CIRM Board Funds its First Clinical Study for COVID-19
Dr. John Zaia, City of hope Today the governing Board of the California Institute for Regenerative Medicine (CIRM) continued its commitment to help with the coronavirus pandemic by awarding $749,999 to Dr. John Zaia at City of Hope. He will be conducting a clinical study to administer blood plasma from recovered COVID-19 patients to treat … Continue reading CIRM Board Funds its First Clinical Study for COVID-19
Stem cell clinical trial for COVID-19 patients gets emergency federal approval
Dr. Camillo Ricordi, principal investigator of a stem cell trial for COVID-19 at the University of Miami Miller School of Medicine Image Credit: Diabetes Research Institute Foundation Website A team of doctors at the University of Miami (UM) Miller School of Medicine received emergency approval from the U.S. Food and Drug Administration (FDA) to conduct a … Continue reading Stem cell clinical trial for COVID-19 patients gets emergency federal approval
Study shows that exercise rejuvenates muscle stem cells of old mice
Dr. Thomas Rando, Stanford University While we're all at home and practicing social distancing during this global pandemic, it has become a challenge to get in daily exercise. Aside from outward physical appearance, what other benefits does exercise hold? Dr. Thomas Rando and his team at Stanford University explored this question in more detail in … Continue reading Study shows that exercise rejuvenates muscle stem cells of old mice
CIRM Board Expands COVID-19 Efforts
Coronavirus particles, illustration. Courtesy KTSDesign/Science Photo Library This past Friday, the governing Board of the California Institute for Regenerative Medicine (CIRM) expanded the eligibility criteria for COVID-19 related projects to develop new treatments against the virus. Just two weeks ago, the Board approved $5 million in emergency funding for COVID-19 research. One major addition is allowing research related … Continue reading CIRM Board Expands COVID-19 Efforts
Novel clinical trial for COVID-19 using immune cells
This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (blue/pink) cultured in the lab. Image Credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories During this global pandemic, many scientists are pursuing various avenues for … Continue reading Novel clinical trial for COVID-19 using immune cells
From bench to bedside – CIRM plays a vital role in accelerating science
Dr. Maria T. Millan, President & CEO of CIRM The field of stem cell research and regenerative medicine has exploded in the last few years with new approaches to treat a wide array of diseases. Although these therapies are quite promising, they face many challenges in trying to bring them from the laboratory and into … Continue reading From bench to bedside – CIRM plays a vital role in accelerating science
The Stem Cellar 